Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032)

NCT01293006 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia

Interventions

DRUG: suvorexant
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC